Skip to main navigation Skip to search Skip to main content

Stability of HIV-1 RNA in blood during specimen handling and storage prior to amplification by NASBA-QT

  • S. M. Bruisten
  • , P. Oudshoorn
  • , P. van Swieten
  • , B. Boeser-Nunnink
  • , P. van Aarle
  • , S. P. Tondreau
  • , H. T. Cuypers

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

The influence of different storage temperatures and anticoagulation conditions on the HIV-1 RNA load as measured by NASBA-QT was examined. Blood specimens from 14 HIV-1 infected individuals were processed within 2 h after collection. The HIV-1 RNA load remained stable for at least 6 months when samples were frozen directly at -70 degrees C in lysis buffer. This lysis buffer fully inactivated the virus. When whole EDTA blood was stored, the HIV-1 RNA load was stable for 72 h at 25 degrees C, but it declined within 24 h at 4 degrees C. The HIV-1 RNA load in whole heparinized blood declined significantly after 24 h at both 4 and 25 degrees C. It was slightly lower (average of 0.18 log ml-1) than in whole EDTA blood. At 4 degrees C, the HIV-RNA load in serum and EDTA-plasma stored with lysis buffer did not decline up to 14 days. At + 30 degrees C, however, the load declined significantly after 2 days. Of clinical significance, the mean load in EDTA plasma was 0.5 log ml-1 higher than in serum. This difference was patient dependent (range 0.1-0.7 log ml-1). We thus recommend, for quantifying HIV-1 RNA by NASBA, to use preferably EDTA blood which is kept at room temperature until plasma separation. When using heparinized blood, the plasma should be stored frozen within 8 h
Original languageEnglish
Pages (from-to)199-207
JournalJournal of virological methods
Volume67
Issue number2
DOIs
Publication statusPublished - 1997

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Stability of HIV-1 RNA in blood during specimen handling and storage prior to amplification by NASBA-QT'. Together they form a unique fingerprint.

Cite this